Reported about 21 hours ago
Anne Wojcicki successfully secured a $305 million bid for 23andMe, surpassing Regeneron Pharmaceuticals' previous offer during a bankruptcy auction. Following a decline in demand and a significant data breach, 23andMe filed for bankruptcy earlier this year. The deal is expected to finalize after a court hearing on June 17, with assurances to maintain customer privacy.
Source: YAHOO